Key result
Transgenic pigs expressing antiviral shRNAs exhibited 0% mortality and reduced clinical signs when challenged with classical swine fever virus, compared to 100% mortality in non-transgenic pigs.
Why the study?
Classical swine fever remains widespread despite eradication efforts, highlighting the urgent need for effective approaches to eradicate classical swine fever virus.
Does CRISPR/Cas9-mediated knock-in of antiviral shRNAs prevent classical swine fever virus infection and mortality in transgenic pigs?
Does CRISPR/Cas9-mediated knock-in of antiviral shRNAs prevent classical swine fever virus infection and mortality in transgenic pigs?
Absolute Event Rate: 0% vs 100%
CRISPR/Cas9-mediated knock-in of antiviral shRNAs successfully generated transgenic pigs with improved resistance to classical swine fever virus, reducing clinical signs and preventing mortality.
Supports CRISPR-edited antiviral resistance in pigs; hypothesis-generating for livestock applications pending field validation.
Classical swine fever (CSF) caused by classical swine fever virus (CSFV) is one of the most detrimental diseases, and leads to significant economic losses in the swine industry.Despite efforts by many government authorities to stamp out the disease from national pig populations, the disease remains widespread.Here, antiviral small hairpin RNAs (shRNAs) were selected and then inserted at the porcine Rosa26 (pRosa26) locus via a CRISPR/ Cas9-mediated knock-in strategy.Finally, anti-CSFV transgenic (TG) pigs were produced by somatic nuclear transfer (SCNT).Notably, in vitro and in vivo viral challenge assays further demonstrated that these TG pigs could effectively limit the replication of CSFV and reduce CSFV-associated clinical signs and mortality, and disease resistance could be stably transmitted to the F1-generation.Altogether, our work demonstrated that RNA interference (RNAi) technology combining CRISPR/Cas9 technology offered the possibility to produce TG animal with improved resistance to viral infection.The use of these TG pigs can reduce CSF-related economic losses and this antiviral strategy may be useful for future antiviral research. Author summaryClassical swine fever (CSF), caused by classical swine fever virus (CSFV), and is a highly contagious, often fatal porcine disease that causes significant economic losses.Due to the economic importance of this virus to the pig industry, the biology and pathogenesis of CSFV have been investigated extensively.Despite efforts by many government authorities to stamp out the disease from national pig populations, the disease remains widespread, and it is only a matter of time before the virus is reintroduced and the next round of disease outbreaks occurs.These findings highlight the necessity and urgency for developing effective approaches to eradicate the challenging CSFV.In this study, we successfully produced anti-CSFV TG pigs by combining RNAi technology and CRISPR/Cas9
No takes yet. Share an insight, caveat, or question.
Xie et al. (2018) studied Classical swine fever virus (CSFV) infection (n=14). CRISPR/Cas9-mediated knock-in of antiviral shRNAs vs. Non-transgenic (NTG) pigs was evaluated on Mortality. Transgenic pigs expressing antiviral shRNAs exhibited 0% mortality and reduced clinical signs when challenged with classical swine fever virus, compared to 100% mortality in non-transgenic pigs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: